Lead Change Blog

JULY 6, 2015

This singular emphasis on results can, however, cause players to operate from an “I win, you lose” philosophy – and act to inhibit others’ performance while they maximize their own. If the only things that leaders demand are results and performance, players in your organization will do their best to deliver those things.

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

The Horizons Tracker

SEPTEMBER 21, 2023

New markets The data implies a lively market for CEOs, enticed by the prospect of elevated remuneration, reduced public scrutiny, and the operational proficiency that private equity (PE) firms offer. After successfully taking Nielsen public, he went on to become a senior executive at The Blackstone Group, overseeing portfolio operations.

Press Release 114

Press Release CEO Pharmaceuticals Industry 114

Tanveer Naseer

AUGUST 2, 2016

These conversations with my daughter about her work has lead to recollections of my summer job experiences, and how one in particular has helped to shape my understandings of leadership and empowering employees.

Pharmaceuticals 100

Pharmaceuticals Loyalty Learning-by-Doing Project 100

Chartered Management Institute

MAY 17, 2023

To explore how collaborative leadership works in practice, we talked to Emma Bould CMgr FCMI, who has spent her career in engineering leadership roles. The amount of leadership training you get in the military is huge ,” she says, “because when you’re placed in an operational role, you have to perform.”

Leadership 59

Leadership How To Pharmaceuticals Resources 59

Marshall Goldsmith

NOVEMBER 4, 2013

The changing role of leadership will mean that the relationship between managers and direct reports will have to change in both directions. Many leaders will be operating more like the managing director of a consulting firm. The same trend is occurring in pharmaceuticals and telecommunications. Employee Engagement Leadership'

Short-term 107

Short-term Long-term Trends Report 107

Eric Jacobson

JULY 8, 2024

Revolutionize health care, making individualized, targeted pharmaceuticals more affordable. And away from work, Kahn forecasts that AI will : Revamp education, meaning children around the world can have personal, portable tutors. Compel us to reimagine how we make art, compose music, and write and publish books.

Tacit Knowledge 81

Tacit Knowledge Competitive Advantage Pharmaceuticals Magazine 81

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. Many innovative ideas became the victims of in-fighting among managers who had competing objectives.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. Paul Garbett for HBR. It’s not that development itself isn’t important.

Leadership Pipeline 15

Leadership Pipeline Leadership After Action Review Pharmaceuticals 15

Strategy Driven

MARCH 18, 2011

Those companies that ‘sweat’ their capabilities continuously improve them and sustainably capture the top-line growth in their industries and, ultimately, market leadership. Companies today operate in a business environment that encourages incoherence. Second, a coherent system focuses strategic investment on what matters.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. That, in brief, is the concept of a leadership circle. While a natural inclination, this group is (by design) representative of current operating units and functions, which often have a status quo to defend.

Leadership 14

Leadership Diversity Committee Long-term 14

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. My senior executives and I made our values the language of leadership. This must come from the top.

Company 13

Company Pharmaceuticals Biotechnology Short-term 13

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 16

COO Sample Telecommunications Automotive 16

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. When innovations don't fit neatly into the slots that already exist, innovators must operate by stealth, going around the establishment.

Health Care 17

Health Care Innovation Pharmaceuticals Consensus 17

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S. Visa restrictions also limit U.S.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

NOVEMBER 15, 2018

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. PM Images/Getty Images. ” Clearly, more is needed.

Cost 14

Cost System Management Franchising 14

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. The reporting lets executive leadership know precisely what is happening and unlocks frontline wisdom.

Health Care 14

Health Care System Metrics Report 14

Harvard Business Review

SEPTEMBER 29, 2011

In explaining pharmaceutical firm GlaxoSmithKline's decision in 2009 to end this practice, CEO Andrew Witty said that "the company's decision was driven by the long-term nature of the pharmaceutical industry, which meant short-term financial indicators were of limited use.". CEOs should actively court desirable investors.

Long-term 15

Long-term CEO Short-term Asset Management 15

Harvard Business Review

JANUARY 15, 2017

We also discovered a staggering lack of confidence in leadership: 71% of survey respondents said government officials are not at all or somewhat credible, and 63% said the same about CEOs. For example, 82% of respondents said that the pharmaceutical industry needs greater regulation. Related Video.

Survey 15

Survey Media Globalization Policies 15

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 16

Rogers Morale Long-term Pharmaceuticals 16

Harvard Business Review

AUGUST 8, 2018

But how well schools meet this goal, and to what extent their teaching influences their students’ leadership, is an open question. As chief executive, Dolan followed the agency-theoretic prescription that was taught in business schools in the late 1970s, refocusing his company’s business almost exclusively on pharmaceuticals.

Influence 15

Influence Education Pharmaceuticals CEO 15

Harvard Business Review

JANUARY 22, 2014

The first concerns a complex transatlantic acquisition of a biotech company by a pharmaceutical company. There were major overlaps in corporate and operational management positions, but most employees would be retained. And, judging from employee surveys, most managers rose to the leadership challenge.

Pharmaceuticals 9

Pharmaceuticals Uncertainty How To Middle Management 9

Harvard Business Review

JUNE 22, 2016

For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social? Organizational transformation must begin with a leadership transformation.

Intangible Assets 14

Intangible Assets Business Model How To Intellectual Capital 14

Harvard Business Review

SEPTEMBER 26, 2011

Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. To my surprise, investors understood and approved of our decision: Merck's stock went up 2.9% the day we made the announcement and continued to rise in the following days.

CEO 17

CEO Short-term Long-term Pharmaceuticals 17

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 10

Health Care Retail Mayo Pharmaceuticals 10

Harvard Business Review

APRIL 7, 2015

Having managed or worked with clinical leaders in care-delivery organizations, the pharmaceutical industry, and government, I have observed three skills that are critical to the success of doctors and nurses as they make the transition to management: Operations management and execution. People leadership.

Execution 8

Execution Skills Health Care Porter 8

Harvard Business Review

FEBRUARY 10, 2014

Change management Customer service Informal leadership' If you’re like most of the managers I’ve met since 2006, you are probably knee-deep in the challenge of identifying excellence and spreading it to more people and places – and we can all keep learning from each other.

Case Study 14

Case Study Pharmaceuticals Airlines Hotels 14

Harvard Business Review

JUNE 30, 2014

Places full of highly mobile and in-demand workers operate more democratically. Third, and even tricker to manage, effective leaders are given credit for their political skills, both as they rise through the organization and as they operate at the top. Consulting Leadership Leadership development' How do they do that?

Politics 10

Politics Pharmaceuticals Consultative Consensus 10

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

OCTOBER 25, 2018

Consider the following hypothetical progression that a pharmaceutical company might go through: Purpose: Increase medication adherence among patients who have been prescribed Drug X. Uncertainty is far more palatable — and far less problematic — when you know precisely where it exists than when it pervades your entire operation.

How To 15

How To Pharmaceuticals Process Organization 15

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Pharmaceuticals Stephenson Globalization 8

Harvard Business Review

JULY 6, 2017

The executives came from a wide array of industries, including financial services, pharmaceuticals, and media. They were more likely to operate based on black-and-white ideals, such as, “There is one best idea that should prevail” or “I am running a pure meritocracy.”

Execution 15

Execution 360-Degree Feedback Executive Coaching Sample 15

Harvard Business Review

MAY 10, 2013

Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms. As Dell''s public statements have pronounced, these changes will reduce near-term profitability, raise operating and capital expenditures and involve a lot of risk. So we are left with a quandary.

Venture Capitalist 10

Venture Capitalist Competitive Advantage Restructuring Short-term 10

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 27, 2015

One notable critic, Warren Bennis, a renowned leadership scholar from the University of Southern California, states that business schools have “an overemphasis on the rigor and an underemphasis on relevance.” Business schools responded. Now, years later, educators have been criticized for going too far.

Company 8

Company Education Pharmaceuticals Project 8